- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 760
Collective Health cruises to $205m round
The enterprise health plan software provider has now raised more than $430m in total, with SoftBank Vision Fund leading a round that also featured GV.
Jun 18, 2019Minute Media wins $40m
The sports content publishing platform increased its overall funding to $120m with a ProSiebenSat.1-backed round that will enable it to extend its M&A activities.
Jun 18, 2019PeopleFund crowds in extra series B financing
Peer-to-peer lending platform PeopleFund has added $5m of equity and $30m of debt to a series B round that already included contributions from KakaoPay and Dayli Financial.
Jun 18, 2019Traction Guest signs in $13m
Salesforce Ventures has invested in Traction Guest, developer of a digital corporate sign-in system, as part of its series A round.
Jun 17, 2019CreatorIQ scores $12m in series B round
Unilever Ventures contributed to the infleuncer marketing platform's latest round, which was led by growth equity firm TCV Capital.
Jun 17, 2019Daily deal net: June 17, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Jun 17, 2019Hyundai helps hike Aurora series B to $600m
Hynudai and Kia Motors took part in a tranche that expanded the driverless car technology developer's latest round, which includes Shell and Amazon, past $600m.
Jun 17, 2019Quartet uncorks $60m series D
GV and new strategic partner Centene both participated in a round that boosted the collaborative mental healthcare platform’s total funding to $153m.
Jun 17, 2019Corporates align with Purigen in series B round
Roche participated in the Agilent Technologies-led round, which will fund the launch of Stanford spinout Purigen's isotachophoresis-based DNA and RNA sample preparation platform.
Jun 17, 2019Blackthorn racks up $76m in series B
The neurobehavioural disorder drug developer sourced funding from investors including Scripps Research, Alphabet, Alexandra Real Estate Equities and Johnson & Johnson in the round.
Jun 17, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


